These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11468183)

  • 21. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
    Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
    Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL.
    Best OG; Gardiner AC; Majid A; Walewska R; Austen B; Skowronska A; Ibbotson R; Stankovic T; Dyer MJ; Oscier DG
    Leukemia; 2008 Jul; 22(7):1456-9. PubMed ID: 18200038
    [No Abstract]   [Full Text] [Related]  

  • 23. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
    Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
    EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin.
    Navrkalova V; Sebejova L; Zemanova J; Kminkova J; Kubesova B; Malcikova J; Mraz M; Smardova J; Pavlova S; Doubek M; Brychtova Y; Potesil D; Nemethova V; Mayer J; Pospisilova S; Trbusek M
    Haematologica; 2013 Jul; 98(7):1124-31. PubMed ID: 23585524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
    Song H; Hollstein M; Xu Y
    Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ionizing radiation can induce GSK-3beta phosphorylation and NF-kappaB transcriptional transactivation in ATM-deficient fibroblasts.
    Kwon O; Kim KA; He L; Kim SO; Kim MS; Cha EY; Yoon BD; Sok DE; Jung M; Ahn JS; Kim BY
    Cell Signal; 2008 Apr; 20(4):602-12. PubMed ID: 18243662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system.
    Chong MJ; Murray MR; Gosink EC; Russell HR; Srinivasan A; Kapsetaki M; Korsmeyer SJ; McKinnon PJ
    Proc Natl Acad Sci U S A; 2000 Jan; 97(2):889-94. PubMed ID: 10639175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human PTIP facilitates ATM-mediated activation of p53 and promotes cellular resistance to ionizing radiation.
    Jowsey PA; Doherty AJ; Rouse J
    J Biol Chem; 2004 Dec; 279(53):55562-9. PubMed ID: 15456759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression and clinical significance of P53 pathway-associated proteins in pancreatic carcinoma].
    Yu GZ; Zhu MH; Chen Y; Ni CR; Li FM
    Ai Zheng; 2005 Nov; 24(11):1398-403. PubMed ID: 16552971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of abnormalities of TP53 and ATM genes for course of B-cell chronic lymphocytic leukemia].
    Rupniewska ZM; Wasik-Szczepanek E
    Postepy Hig Med Dosw; 2001; 55(6):815-28. PubMed ID: 11875779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.
    Pereg Y; Shkedy D; de Graaf P; Meulmeester E; Edelson-Averbukh M; Salek M; Biton S; Teunisse AF; Lehmann WD; Jochemsen AG; Shiloh Y
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5056-61. PubMed ID: 15788536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease.
    Goodman JE; Hofseth LJ; Hussain SP; Harris CC
    Environ Mol Mutagen; 2004; 44(1):3-9. PubMed ID: 15199542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer.
    Knappskog S; Chrisanthar R; Løkkevik E; Anker G; Østenstad B; Lundgren S; Risberg T; Mjaaland I; Leirvaag B; Miletic H; Lønning PE
    Breast Cancer Res; 2012 Mar; 14(2):R47. PubMed ID: 22420423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to activate p53.
    Caspari T
    Curr Biol; 2000 Apr; 10(8):R315-7. PubMed ID: 10801407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease.
    Best OG; Che Y; Singh N; Forsyth C; Christopherson RI; Mulligan SP
    Leuk Lymphoma; 2012 Jul; 53(7):1367-75. PubMed ID: 22149137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alteration of the ATM gene occurs in gastric cancer cell lines and primary tumors associated with cellular response to DNA damage.
    Zhang L; Jia G; Li WM; Guo RF; Cui JT; Yang L; Lu YY
    Mutat Res; 2004 Jan; 557(1):41-51. PubMed ID: 14706517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia.
    Ouillette P; Li J; Shaknovich R; Li Y; Melnick A; Shedden K; Malek SN
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1125-32. PubMed ID: 22952040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas.
    Angèle S; Treilleux I; Tanière P; Martel-Planche G; Vuillaume M; Bailly C; Brémond A; Montesano R; Hall J
    Clin Cancer Res; 2000 Sep; 6(9):3536-44. PubMed ID: 10999741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression.
    Guarini A; Marinelli M; Tavolaro S; Bellacchio E; Magliozzi M; Chiaretti S; De Propris MS; Peragine N; Santangelo S; Paoloni F; Nanni M; Del Giudice I; Mauro FR; Torrente I; Foà R
    Haematologica; 2012 Jan; 97(1):47-55. PubMed ID: 21993670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype.
    Gueven N; Becherel OJ; Birrell G; Chen P; DelSal G; Carney JP; Grattan-Smith P; Lavin MF
    Cancer Res; 2006 Mar; 66(6):2907-12. PubMed ID: 16540636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.